Search - tctmd.com

Displaying 921 - 940 of 3616

Sort: Relevancy | Date

Presentation TCT 2015

HOT TOPIC 4: Debate Is Big Data the Future of Comparative-Effectiveness Analysis? Maybe, but Be Afraid, Be Very Afraid!

Presenter: Bernard J. Gersh, William S. Weintraub, Robert A. Harrington

October 12, 2015

Presentation TCT 2015

HOT TOPIC 4: Debate Is Big Data the Future of Comparative-Effectiveness Analysis? Yes, the Writing Is in the Cloud!

Presenter: Bernard J. Gersh, William S. Weintraub, Matthew T. Roe

October 12, 2015

Presentation TCT 2015

HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Clinicians Perspective

Presenter: Bernard J. Gersh, William S. Weintraub, Ajay J. Kirtane

October 12, 2015

Presentation TCT 2015

HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Guideline Perspective

Presenter: Bernard J. Gersh, William S. Weintraub, Patrick T. O'Gara

October 12, 2015

Presentation TCT 2015

BIOSOLVE II: Evaluation of a Sirolimus-Eluting Bioresorbable Metallic Scaffold - Six-Month Clinical, Angiographic and Imaging Outcomes

Presenter: Ioanna Kosmidou, Michael Haude

October 12, 2015

Presentation TCT 2015

HOT TOPIC 2: Balancing Safety and Efficacy Endpoints How Do Net Clinical Benefit and Quality of Life Fit Into the Equation? FOCUS on DAPT, PEGASUS, and MATRIX: Statistical Perspective

Presenter: Bernard J. Gersh, William S. Weintraub, Stuart J. Pocock

October 12, 2015

Presentation TCT 2015

HOT TOPIC 2: Balancing Safety and Efficacy Endpoints How Do Net Clinical Benefit and Quality of Life Fit Into the Equation? FOCUS on DAPT, PEGASUS, and MATRIX: Clinical/Trialist Perspective

Presenter: Bernard J. Gersh, William S. Weintraub, Gregg W. Stone

October 12, 2015

Presentation TCT 2015

HOT TOPIC 1: Should Small Randomized Trials Be Practice Changing? FOCUS on PRAMI and WOEST Clinician's Perspective

Presenter: Bernard J. Gersh, William S. Weintraub, Eric R. Bates

October 12, 2015

Presentation TCT 2015

HOT TOPIC 1: Should Small Randomized Trials Be Practice Changing? FOCUS on PRAMI and WOEST Trialist/Guideline Perspective

Presenter: Bernard J. Gersh, William S. Weintraub, John A. Bittl

October 12, 2015

Presentation TCT 2015

The TRYTON PIVOTAL: Randomized Trial and Confirmatory Study: Dedicated Bifurcation Stent in Coronary Bifurcation Involving Large Side Branches

Presenter: Spencer B. King III, Jagat Narula, Philippe Généreux

October 12, 2015

Presentation TCT 2015

CENTURY II: A Prospective Randomized Trial of a Bioabsorbable-Polymer Biolimus-Eluting Stent Versus a Durable-Polymer Everolimus-Eluting Stent in Patients With Coronary Artery Disease Two-Year Outcomes

Presenter: Spencer B. King III, Jagat Narula, Shigeru Saito

October 12, 2015

Presentation TCT 2015

DAPT: A Prospective, Double-blind, Placebo-controlled Randomized Trial of 1-year Versus 2.5 Years of Dual Anti-platelet Therapy (Everolimus-Eluting Stent-Treated Subset)

Presenter: Spencer B. King III, Jagat Narula, James B. Hermiller Jr

October 12, 2015

Presentation TCT 2015

A Prospective Randomized Trial of Transradial vs Transfemoral Access in Patients Undergoing Coronary Angiography and Intervention

Presenter: Shigeru Saito, Gregg W. Stone, Ron Waksman, Shigeru Saito

October 12, 2015

Presentation TCT 2015

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Run-Lin Gao, Gregg W. Stone, Ron Waksman, Run-Lin Gao

October 12, 2015

Presentation TCT 2015

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Gregg W. Stone, Ron Waksman, Dean J. Kereiakes

October 12, 2015

News Industry News

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

October 12, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Industry News

Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants

October 12, 2015

News Industry News

Lilly to Discontinue Development of Evacetrapib for High-Risk Atherosclerotic Cardiovascular Disease

October 12, 2015

News Conference News TCT 2015

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

October 12, 2015

Advertisement

HOT TOPIC 4: Debate Is Big Data the Future of Comparative-Effectiveness Analysis? Maybe, but Be Afraid, Be Very Afraid!

HOT TOPIC 4: Debate Is Big Data the Future of Comparative-Effectiveness Analysis? Yes, the Writing Is in the Cloud!

HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Clinicians Perspective

HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Guideline Perspective

BIOSOLVE II: Evaluation of a Sirolimus-Eluting Bioresorbable Metallic Scaffold - Six-Month Clinical, Angiographic and Imaging Outcomes

HOT TOPIC 2: Balancing Safety and Efficacy Endpoints How Do Net Clinical Benefit and Quality of Life Fit Into the Equation? FOCUS on DAPT, PEGASUS, and MATRIX: Statistical Perspective

HOT TOPIC 2: Balancing Safety and Efficacy Endpoints How Do Net Clinical Benefit and Quality of Life Fit Into the Equation? FOCUS on DAPT, PEGASUS, and MATRIX: Clinical/Trialist Perspective

HOT TOPIC 1: Should Small Randomized Trials Be Practice Changing? FOCUS on PRAMI and WOEST Clinician's Perspective

HOT TOPIC 1: Should Small Randomized Trials Be Practice Changing? FOCUS on PRAMI and WOEST Trialist/Guideline Perspective

The TRYTON PIVOTAL: Randomized Trial and Confirmatory Study: Dedicated Bifurcation Stent in Coronary Bifurcation Involving Large Side Branches

CENTURY II: A Prospective Randomized Trial of a Bioabsorbable-Polymer Biolimus-Eluting Stent Versus a Durable-Polymer Everolimus-Eluting Stent in Patients With Coronary Artery Disease Two-Year Outcomes

DAPT: A Prospective, Double-blind, Placebo-controlled Randomized Trial of 1-year Versus 2.5 Years of Dual Anti-platelet Therapy (Everolimus-Eluting Stent-Treated Subset)

A Prospective Randomized Trial of Transradial vs Transfemoral Access in Patients Undergoing Coronary Angiography and Intervention

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants

Lilly to Discontinue Development of Evacetrapib for High-Risk Atherosclerotic Cardiovascular Disease

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content